We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, CMS Extend Parallel Review Pilot Program for Two More Years
FDA, CMS Extend Parallel Review Pilot Program for Two More Years
The FDA and the Centers for Medicare & Medicaid Services announced Wednesday a two-year extension of the parallel review pilot program for medical devices, saying they need more time to evaluate the program’s effectiveness.